Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chaetodontoplus conspicillatus

ABSTRACT: Chaetodontoplus conspicillatus Genome sequencing

PROVIDER: PRJNA306927 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR3056099_1.fastq.gz	Fastqsanger.gz
	SRR3056099_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Chaetodontoplus conspicillatus

Project description:Chaetodontoplus conspicillatus overview

| PRJNA306963 | ENA

Chaetodontoplus mesoleucus

Project description:Chaetodontoplus mesoleucus Genome sequencing

| PRJNA306971 | ENA

Forpus conspicillatus

Project description:Forpus conspicillatus

| PRJNA703699 | ENA

Chaetodontoplus mesoleucus

Project description:Chaetodontoplus mesoleucus overview

| PRJNA307012 | ENA

Chaetodontoplus poliourus

Project description:Chaetodontoplus poliourus overview

| PRJNA793967 | ENA

Pelecanus conspicillatus strain:NA

Project description:Pelecanus conspicillatus

| PRJNA964810 | ENA

Zosterops conspicillatus strain:NA

Project description:Zosterops conspicillatus

| PRJNA969964 | ENA

Chaetodontoplus poliourus

Project description:Chaetodontoplus poliourus Raw sequence reads

| PRJNA686511 | ENA

Project description:Genome sequencing of Chaetodontoplus poliourus

| PRJNA686515 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data